Revenue: $25 to $50 million (USD) Competitors: Unknown. Venatorx Pharmaceuticals is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. Founded in 2010, Venatorx has built a world-class in-house
Venatorx Pharmaceuticals is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. Founded in 2010, we believe Venatorx has built a world-class in-house R&D organization that has filed over 100 patents spanning multiple research programs.
PROJECT SUMMARY Novel therapies for the treatment of chikungunya virusCHIKVinfections are urgently needed to address the alarming spread of this pathogen across the AmericasWe have identified three di
(610) 644-8935 Where are Venatorx’s headquarters? Venatorx’s headquarters are in 74 E. Swedesford Road, Suite 100, Malvern, Pennsylvania, 19355, United States What is Venatorx’s phone number? Venatorx’s phone number is (610) 644-8935 What is Venatorx’s official website? Venatorx’s official website is //www.venatorx.com What is Venatorx’s Revenue?
Dr. Burns is Founder, President and CEO of Venatorx Pharmaceuticals, a world leader in antibacterial and antiviral drug research and development. He has 30 years’ experience in the pharmaceutical industry, including various corporate and R&D leadership positions at Protez/Novartis, ViroPharma, and Rhone-Poulenc Rorer (now Sanofi).
(610) 644-8935 Business Contact. Name: DANIEL PEVEAR. Phone: (610) 644-8935. Email: pevear@ venatorx.com. Research Institution. N/A. Abstract. Ebola viruses (EBOV) cause severe illnesses in humans with a high rate of mortality that approaches 90%. Novel therapies with potent and selective activity against EBOV are urgently needed for the prevention and.
VenatoRx. Venatorx Pharmaceuticals is a private pharmaceutical company focused on the discovery and development of novel anti-infectives to treat multi-drug resistant (MDR) bacterial infections and hard-to-treat viral infections.
About us. Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections. The company name, Venatorx (ven-a-TOREX), derives from the Latin word “venator”, meaning ‘hunter’ and “rx”, the
Venatorx’s Records of Processing Activities (RoPA) was then drafted as required by Article 30 of the GDPR. The DPO Centre also provided virtual GDPR training for Venatorx employees. This encompassed learning how the GDPR applies to a US-based pharmaceutical company, and what staff should be aware of when handling patient data.
Venatorx Pharmaceuticals has 6 current employee profiles, including Chief Business Officer Tony Meehan, PhD. Tony Meehan, PhD Chief Business Officer. Christopher J. Burns, PhD Founder, President and CEO. Daniel C. Pevear, PhD Founder and Senior Vice President, Biology and Grants Development. Luigi Xerri, PhD Founder, Senior Strategic Advisor
Dr. Burns is Founder, President and CEO of Venatorx Pharmaceuticals, a world leader in antibacterial and antiviral drug research and development. He has 30 years’ experience in the pharmaceutical industry, including various corporate and R&D leadership positions at Protez/Novartis, ViroPharma, and Rhone-Poulenc Rorer (now Sanofi).
About Venatorx Pharmaceuticals. Venatorx Pharmaceuticals is a private company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to ...
Company Profile for VenatoRx Pharmaceuticals, Inc. January 15, 2019 10:00 AM Eastern Standard Time --( BUSINESS WIRE )--VenatoRx Pharmaceuticals is a world leader in antibacterial and antiviral
Venatorx Pharmaceuticals to Present Data at IDWeek 2021. 9/27/2021. Venatorx Pharmaceuticals today announced that the Company, along with its collaborators, will present seven posters and two oral abstracts at IDWeek 2021, which is taking place virtually September 29 – October 3, 2021.
610-644-8935 Contact Email [email protected] Phone Number 610-644-8935 VenatoRx is a private pharmaceutical company focused on the discovery and development of ...
Venatorx Pharmaceuticals today announced that Scott McConnell, Pharm.D. has joined the Company as Vice President, Medical Affairs. With over 20 years’ experience in infectious disease, oncology
(610) 644-8935 Contact Venatorx Phone: (610) 644-8935 General Inquiries: contact(at)venatorx(dot)com Medical/Scientific Inquiries: medinfo(at)venatorx(dot)com
+1 (610) 000-0000 Contact Information Website www.venatorx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Pharmaceuticals Biotechnology Primary Office 74 East Swedesford Road Suite 100 Malvern, PA 19355 United States +1 (610) 000-0000 Want detailed data on 3M+ companies?
Venatorx is a private pharmaceutical company that is focused on the discovery and development of novel anti-infectives to treat multi-drug-resistant bacterial infections and hard-to-treat viral infections. Founded in 2010, Venatorx has built a world-class in-house research and discovery organization that has filed over 100 patents spanning